Title: | Predictors of cardiovascular mortality after an electrical storm in patients with structural heart disease |
Authors: | Koizumi, Takuya Browse this author |
Kamada, Rui Browse this author →KAKEN DB |
Watanabe, Masaya Browse this author →KAKEN DB |
Yokoshiki, Hisashi Browse this author |
Temma, Taro Browse this author |
Hagiwara, Hikaru Browse this author |
Koya, Taro Browse this author |
Nakao, Motoki Browse this author |
Kadosaka, Takahide Browse this author |
Natsui, Hiroyuki Browse this author |
Takahashi, Masayuki Browse this author |
Mizukami, Kazuya Browse this author |
Mitsuyama, Hirofumi Browse this author |
Anzai, Toshihisa Browse this author →KAKEN DB |
Keywords: | Electrical storm |
Defibrillator shock |
Cardiovascular mortality |
Heart failure |
Issue Date: | Aug-2022 |
Publisher: | Elsevier |
Journal Title: | Journal of cardiology |
Volume: | 80 |
Issue: | 2 |
Start Page: | 167 |
End Page: | 171 |
Publisher DOI: | 10.1016/j.jjcc.2022.02.016 |
Abstract: | Background: Electrical storms (ESs) in patients with structural heart disease (SHD) have been reported to be associated with a poor prognosis. However, the detailed cause of death and influence of implantable cardioverter defibrillator (ICD) therapy in ES patients have not been fully investigated. Therefore, we sought to explore the detailed clinical course after an ES and the impact of the ICD therapy in patients with SHDs. Methods: We retrospectively analyzed 31 consecutive patients with ESs who had undergone a n1CD implantation. ESs were defined as three or more ventricular arrhythmias within 24 h. Results: During a mean follow up of 4.5 years, 13 patients died. Among them, cardiovascular death (CVD) was observed in 11/13 (85%), and the leading cause of the CVD was end-stage heart failure. A New York Heart Association class >= III at the time of the ES occurrence (HR 6.51 95% CI 1.94-25.1, p = 0.003) and any shock therapy (HR 5.94 95% CI 1.06-112.2, p = 0.04) were associated with CVD. Conclusion: In the current single center study, the major cause of death in ES patients with SHDs was end-stage heart failure. Any shock therapy was associated with CVD. Arrhythmia management to avoid ICD shocks might reduce the mortality in ES patients. (C) 2022 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved. All rights reserved. |
Type: | article |
URI: | http://hdl.handle.net/2115/87795 |
Appears in Collections: | 北海道大学病院 (Hokkaido University Hospital) > 雑誌発表論文等 (Peer-reviewed Journal Articles, etc)
|